Tl. Babb et al., Brain plasticity and cellular mechanisms of epileptogenesis in human and experimental cortical dysplasia, EPILEPSIA, 41, 2000, pp. S76-S81
Purpose: The cellular mechanisms that may contribute to epilepsy in resecte
d human cortical dysplasia (CD) were compared with the in utero radiated ra
t CD model. In human and rat focal hippocampal epilepsy, postsynaptic N-met
hyl-D-aspartate receptors are up-regulated and presynaptic axon collaterals
hyperinnervate them. We hypothesized that in both human and rat CD: (a) th
e N-methyl-D-aspartate receptor subunits NR1 and NR2A/B would be increased
and coassembled, and (b) aberrant axons would be in regions of CD.
Methods: Tests for presynaptic and postsynaptic changes in human and rat CD
included the following: (a) cytology, (b) immunocytochemistry, (c) coimmun
oprecipitation, (d) double-labeled immunofluorescence, and (e) Timm histoch
emistry of hippocampal mossy fibers. Within-patient comparisons were made b
etween epileptic tissue, identified by subdural electroencephalographic sei
zure onsets, and nonepileptic tissue remote from the focus but within the t
herapeutic resection. Rats were radiated at embryonic day 17, and offspring
were studied postnatally. Statistical comparisons were made against normal
rats matched for age and tissue processing.
Results: In focal CD patients, NR2A/B subunits and their coassemblies with
NR1 were increased significantly more than for the remote nonepileptic cort
ex. Confocal microscopy showed that NR1-NR2A/B colabeled single dysplastic
neurons in both human and rat. In CD rats, mossy fibers innervated the anom
alously oriented hippocampal neurons.
Conclusions: Human epileptic CD exhibits a spectrum of abnormal cell orient
ations and laminations that must require plastic axodendritic changes durin
g development. These: altered circuits and receptors could account for the
seizures and cognitive deficits found in patients with CD. The radiated rat
CD model with cortical dyslaminations and NR2A/B subunit increases would a
llow the development and testing of drugs targeted at only the NR2A/B subun
it or at decoupling the NR1-NR2 coassembly, which could provide a specific
antiepileptic drug for dysplastic circuits without inducing general depress
ion of all brain neurons.